AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SAN ANTONIO, May 4 /PRNewswire/ -- KADIAN(R) improves pain scores and pain symptoms in arthritis and fibromyalgia syndrome (FMS) patients to the same degree as patients with other moderate to severe chronic non-malignant pain states, according to two supplemental analyses presented at the 25th Annual Scientific Meeting of the American Pain Society.
"Opioid use in this patient population may be considered after first-line treatment has failed and these data further support this conclusion," said study investigator Bruce Nicholson, MD, Director, Pain Specialists of Greater Lehigh Valley, Inc. "KADIAN(R) demonstrated efficacy and safety in these patient groups."
These sub-analyses are from a large, demographically diverse, community-based study population. A total of 1,428 patients were enrolled by investigators at 202 community-based pain centers. Of these, 1,418 non-malignant pain patients were included in the safety population, and 1,150…
Source: HighBeam Research, KADIAN(R) (morphine sulfate extended-release) Capsules Improve Pain...